Type II tRNA cleavage by SLFN14 endoribonuclease variants linked to inherited thrombocytopenia drives global translational repression
PLOS Biology · 29.05.2026 · 24 (5) · e3003830
DOI: 10.1371/journal.pbio.3003830 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 29.05.2026. Verfasst von Chengchao Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Molecular Genetics, Joe R. & Teresa Lozano Long School of Medicine, The University of Texas at San Anton…. Hauptthemen laut MEDLINE: Protein Biosynthesis, Endoribonucleases, RNA, Transfer, Thrombocytopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Texas Health Science Center at San Antonio.
Abstract (Originalsprache)
Schlafens proteins (SLFNs) are interferon-inducible regulators of RNA metabolism that influence antiviral defense and cell fate. Human SLFN14 is a ribosome-associated endoribonuclease whose pathogenic variants cause autosomal dominant inherited thrombocytopenia (IT), but the molecular basis of this disorder remains unclear. Here, using HEK293T cells expressing human SLFN14 variants, we show that SLFN14 represses global protein synthesis through selective cleavage of type II tRNAs. IT-linked mutations alter SLFN14 RNA substrate specificity, enhancing depletion of type II tRNAs while reducing rRNA cleavage. This shift promotes ribosome stalling at codons decoded by type II tRNAs, triggering global translational arrest, stress signaling, and cell death. These findings reveal how altered RNA targeting by SLFN14 can drive disease and highlight selective tRNA targeting as a mechanism than regulates translation and cell fate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Molecular Genetics, Joe R. & Teresa Lozano Long School of Medicine, The University of Texas at San Antonio, San Antonio, Texas, New York, United States of America.
- Department of Infectious Disease, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
- Division of Nutritional Sciences, Cornell University, Texas, New York, United States of America.
ORCID-Profile: Yan Xiang
Förderung
- University of Texas Health Science Center at San Antonio
Zitieren
APA
Ding, C., Liu, X. A., Zhang, F., Uematsu, S., Qian, S. B., & Xiang, Y. (2026). Type II tRNA cleavage by SLFN14 endoribonuclease variants linked to inherited thrombocytopenia drives global translational repression. PLOS Biology, 24(5), e3003830. https://doi.org/10.1371/journal.pbio.3003830
Vancouver
Ding C, Liu XA, Zhang F, Uematsu S, Qian SB, Xiang Y. Type II tRNA cleavage by SLFN14 endoribonuclease variants linked to inherited thrombocytopenia drives global translational repression. PLOS Biology. 2026;24(5):e3003830. doi:10.1371/journal.pbio.3003830
BibTeX
@article{Ding2026,
author = {Ding, Chengchao and Liu, Xinyi Ashley and Zhang, Fushun and Uematsu, Saori and Qian, Shu-Bing and Xiang, Yan},
title = {Type II tRNA cleavage by SLFN14 endoribonuclease variants linked to inherited thrombocytopenia drives global translational repression},
journal = {PLOS Biology},
year = {2026},
volume = {24},
number = {5},
pages = {e3003830},
doi = {10.1371/journal.pbio.3003830}
}
EUVIMED